These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Pathophysiology of myocardial reperfusion injury]. Piper HM; Kasseckert SA; Schlüter KD; Abdallah Y Dtsch Med Wochenschr; 2008 Mar; 133(12):586-90. PubMed ID: 18335390 [TBL] [Abstract][Full Text] [Related]
26. [The biochemical and cellular bases of myocardial ischemia-reperfusion damage]. Téllez F; Carvajal K; García C; Vásquez C; Chávez E; Moreno-Sánchez R Arch Inst Cardiol Mex; 1996; 66(2):162-81. PubMed ID: 8768635 [TBL] [Abstract][Full Text] [Related]
27. Remote Ischemic Conditioning for Patients With STEMI. Schmidt MR; Rasmussen ME; Bøtker HE J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):302-309. PubMed ID: 28381115 [TBL] [Abstract][Full Text] [Related]
28. The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging. Kato M; Akao M; Matsumoto-Ida M; Makiyama T; Iguchi M; Takeda T; Shimizu S; Kita T Cardiovasc Res; 2009 Jul; 83(2):335-44. PubMed ID: 19299432 [TBL] [Abstract][Full Text] [Related]
29. New pharmacologic options in the treatment of acute coronary syndromes and myocardial ischemia-reperfusion injury: potential role of levosimendan. Garcia-Gonzalez MJ; Dominguez-Rodriguez A; Abreu-Gonzalez P Minerva Cardioangiol; 2007 Oct; 55(5):625-35. PubMed ID: 17912166 [TBL] [Abstract][Full Text] [Related]
30. Postconditioning: from experimental proof to clinical concept. Mewton N; Ivanès F; Cour M; Ovize M Dis Model Mech; 2010; 3(1-2):39-44. PubMed ID: 20075381 [TBL] [Abstract][Full Text] [Related]
31. [The effect of cytochrome c on the myocardium during reperfusion]. Boiarinov GA; Iakovlev AIu; Teziaeva SA; Mukhina IV; Boiarinova LV Patol Fiziol Eksp Ter; 1999; (4):20-5. PubMed ID: 10598459 [TBL] [Abstract][Full Text] [Related]
34. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury. Ruiz-Meana M; Rodríguez-Sinovas A; Cabestrero A; Boengler K; Heusch G; Garcia-Dorado D Cardiovasc Res; 2008 Jan; 77(2):325-33. PubMed ID: 18006437 [TBL] [Abstract][Full Text] [Related]
35. Reperfusion injury in ST-segment elevation myocardial infarction: the final frontier. Ndrepepa G; Colleran R; Kastrati A Coron Artery Dis; 2017 May; 28(3):253-262. PubMed ID: 28072597 [TBL] [Abstract][Full Text] [Related]
36. Reperfusion injury: doublethink or misnomer. Sobel BE; Zaman AK Coron Artery Dis; 2011 Nov; 22(7):515-7. PubMed ID: 21849893 [No Abstract] [Full Text] [Related]
37. PPAR-γ and AMPK--advantageous targets for myocardial ischemia/reperfusion therapy. Morrison A; Li J Biochem Pharmacol; 2011 Aug; 82(3):195-200. PubMed ID: 21536015 [TBL] [Abstract][Full Text] [Related]
38. Contribution of calpains to myocardial ischaemia/reperfusion injury. Inserte J; Hernando V; Garcia-Dorado D Cardiovasc Res; 2012 Oct; 96(1):23-31. PubMed ID: 22787134 [TBL] [Abstract][Full Text] [Related]
39. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo. Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286 [TBL] [Abstract][Full Text] [Related]
40. Response to: Effect of inhibition of Na(+)/Ca(+) exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Anderson S Cardiovasc Res; 2002 Sep; 55(4):706-7. PubMed ID: 12176118 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]